FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/05/2026
Voltar para busca
Dado oficial do USPTO
APOLLOX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
22/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 40, 42
Data de depósito
28/08/2024
Data de registro
21/10/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/10/2025
Última transação
22/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
NOLASCO-ARIAS, KENNETH E
Unidade examinadora
M70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Fujifilm Diosynth Biotechnologies UK Limited
Representantes
Allisen Pawlenty Coates IP
Classificação técnica
Classes Nice
Classe 1Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Cell cultures used in industry and science; mammalian cell cultures and vectorsbeing independent replicating pieces of DNA that can transfer DNA sequenceseach for use in industry and science; biological preparations for use in science; biological preparations for use in cell cultures for use in industry and science; cell culture reagents for scientific and research use; media for cell culture for use in industry and science; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes
Classe 40
Processing and manufacturing of vectorscell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufactureprocessing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing of pharmaceuticals; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; cell culture manufacturing services for others; custom manufacture of biologics; informationadvice and consultancy in relation to all the aforesaid
Classe 42
Scientific researchindustrial research in the field of biomanufacturingbioprocessingpharmaceuticals and biopharmaceuticals and technical product research and development services in the field of biomanufacturingbioprocessingpharmaceuticals and biopharmaceuticals; development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; industrial process development in the field of biomanufacturingbioprocessingpharmaceuticals and biopharmaceuticals; development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; technical project studies in the field of biomanufacturingbioprocessingpharmaceuticals and biopharmaceuticals; technical project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; biotechnology product testing services; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; development of processes for use in the manufacture of pharmaceutical and biological products; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; informationadvice and consultancy in relation to all the aforesaid
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
21/05/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/05/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/05/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
30/04/2026
FIMP
FINAL DISPOSITION PROCESSED
30/04/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/01/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
21/10/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/09/2025
PUBO
PUBLISHED FOR OPPOSITION
02/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/07/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
31/07/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
31/07/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
31/07/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
31/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/07/2025
RFNT
REFUSAL PROCESSED BY IB
04/05/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/04/2025
RFRR
REFUSAL PROCESSED BY MPU
11/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/03/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/03/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/03/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/03/2025
CNRT
NON-FINAL ACTION WRITTEN
05/03/2025
DOCK
ASSIGNED TO EXAMINER
04/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
06/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/12/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace APOLLOX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.